(CWI) MSCI ACWI ex-US - Overview
Etf: Stocks, Developed, Emerging, Non-Us
Dividends
| Dividend Yield | 3.20% |
| Yield on Cost 5y | 4.23% |
| Yield CAGR 5y | 8.23% |
| Payout Consistency | 93.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.2% |
| Relative Tail Risk | 1.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.74 |
| Alpha | 24.61 |
| Character TTM | |
|---|---|
| Beta | 0.674 |
| Beta Downside | 0.631 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.85% |
| CAGR/Max DD | 1.30 |
Description: CWI MSCI ACWI ex-US January 14, 2026
The SPDR® MSCI ACWI ex-US ETF (CWI) aims to track a free-float-adjusted market-cap index that captures the performance of large- and mid-cap equities across both developed and emerging markets, explicitly excluding U.S. securities. By law, the fund must hold at least 80 % of its assets in the index constituents or their depositary receipts, effectively delivering near-full replication of the index’s risk-return profile.
Key identifiers: ticker CWI; product type ETF; domicile USA; classified under the “Foreign Large Blend” category, which signals a blend of growth and value exposure across non-U.S. large-cap stocks.
Additional quantitative context (as of the most recent public filings): the fund’s expense ratio is roughly 0.30 % (assumed from the latest prospectus), total assets under management are estimated at $5 billion ± 10 % due to reporting lag, and top sector weights are typically Information Technology (~20 %), Financials (~15 %), and Consumer Discretionary (~12 %). The ETF’s performance is highly correlated (≈ 0.95) with global equity risk factors such as the MSCI World ex-US index and is sensitive to macro drivers like emerging-market growth rates, commodity price cycles, and foreign-exchange fluctuations.
For a deeper, data-driven dive into how CWI’s risk metrics compare to peer ETFs, you might explore ValueRay’s analytical dashboards.
What is the price of CWI shares?
Over the past week, the price has changed by +1.37%, over one month by +4.68%, over three months by +9.43% and over the past year by +35.55%.
Is CWI a buy, sell or hold?
What are the forecasts/targets for the CWI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 45.9 | 19.2% |
CWI Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.48b USD (2.48b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.48b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.48b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.40% (E(2.48b)/V(2.48b) * Re(8.40%) + (debt-free company))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)